2024 ACMT Symposium | SUD in Adolescents & Young Adults
- Registration Closed
2024 ACMT Symposium | Substance Use Disorder in Adolescents and Young Adults: Unique Challenges
April 11, 2024
Omni Shoreham Hotel, Washington, DC
Join the American College of Medical Toxicology (ACMT) and the Maryland-DC Society of Addiction Medicine (MDDCSAM) on Thursday, April 11, 2024 for a Symposium on "Substance Use Disorder in Adolescents and Young Adults: Unique Challenges."
Adolescents comprise approximately 15% of the population, and the number of adolescents who use non-prescribed substances is staggering, with about 2.08 million (8.33%) of 12- to 17-year-olds nationwide reporting use within the past month. Non-prescribed substance use increased 61% among 8th graders between 2016 and 2020. Unfortunately, treatment resources are limited and there is a lack of exposure to training physicians in the treatment of these patients. Additionally, there are unique challenges within this patient population, including the on-going brain development throughout puberty and adolescence that can impact decision making and substance use. Many who are exposed to illicit substances in youth progress to develop substance use disorders as adults.The increasing novelty of substances of abuse, the rise of fentanyl and marijuana use in the adolescent population, and the overall lack of adequate treatment for this group (including medication-assisted therapy) will increase the need to have informed providers to care for this population.
This symposium gathers experts, researchers, and healthcare professionals to explore the unique challenges surrounding adolescent substance use, including biologic differences in adolescents, psycho-social motivational differences, and medication recommendations and therapeutic interventions for this patient population. This educational event is tailored for medical toxicologists, addiction medicine specialists, pediatricians, psychiatrists, psychologists, nurses, and all healthcare providers dedicated to improving the lives of young individuals battling substance use disorders.
Learning Objective 1
Illustrate the epidemiology and trends of adolescent SUD in the United States.
Learning Objective 2
Identify the biological and psycho-social factors that differentiate adolescents from adults in the context of substance use.
Learning Objective 3
Explore multifaceted SUD treatment approaches and gain greater insight into how to tailor treatment plans to meet the unique needs of adolescent patients struggling with substance use.
Continuing Education
Continuing Medical Education (CME), Continuing Pharmacy Education (CPE) and Continuing Nursing Education (CNE) credits are available for this activity for an additional fee. To receive continuing education credits, learners must attend the sessions in-person or watch them on-demand after the event.
Book Hotel
ACMT has secured a discounted rate at the Omni Shoreham Hotel in Washington, DC for attendees of our 2024 ACMT Annual Scientific Meeting & Symposia. We encourage you to book your stay at the Omni Shoreham using the link below for the best selection and price!
Questions?
Please write to ACMT at events@acmt.net
Agenda
This agenda is subject to change. All times listed are in local, Eastern Time Zone.
Thursday, April 11, 2024
9:45 - 10:00 AM - Welcome & Introductions
10:00 - 10:30 AM
Developmental Vulnerabilities in Substance Use Disorders: Why Are Youth Different?
Marc Fishman, MD, FASAM, Medical Director, Maryland Treatment Centers; Addiction Psychiatrist, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Rockville, MD
10:30 - 11:00 AM
Assessment and Treatment of SUD in Youth: Beyond SBIRT
Camille Broussard Robinson, MD, MPH, Assistant Professor of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD
11:00 - 11:30 AM
Opioid Use Disorder in Youth -- When To Consider MAT
Ann B. Bruner, MD, Pediatrician, Mountain Manor Treatment Center, Baltimore, MD
11:30 - 12:15 PM
Family Involvement in Youth SUD Treatment
Kevin Wenzel, PhD, Psychologist and Director of Research, Maryland Treatment Centers, Mountain Manor Treatment Center, Baltimore, MD
12:15 - 1:45 PM - Lunch Break
1:45 - 2:45 PM
Panel | Youth SUD Updates on Patterns & Trends, Vaping & Emerging Substances, and Cannabis
Patterns & Trends
Leslie R. Dye, MD, FACMT, FASAM, FACCT, Clinical Professor, Emergency Medicine, Assistant Medical Director, Wright State University/Boonshoft School of Medicine, OneFifteen, Dayton, OH
Vaping & Emerging Substances
Camille Broussard Robinson, MD, MPH, Division of Adolescent & Young Adult Medicine, Director of Research, Children’s Center Chronic Fatigue Clinic, Johns Hopkins University School of Medicine, Baltimore, MD
Cannabis
Jordan Davidson, Communications and Legislative Affairs Officer, Smart Approaches to Marijuana (SAM), Alexandria, VA
Moderator: Ashley Haynes, MD, FACEP, Medical Toxicologist, Addiction Medicine Specialist, Veterans Health Administration, Andover, KS
2:45 - 3:15 PM
Developmental Effects of Cannabis and Psychiatric Consequences
Marc Fishman, MD, FASAM, Medical Director, Maryland Treatment Centers; Addiction Psychiatrist, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Rockville, MD
3:15 - 3:30 PM - Break
3:30 - 4:15 PM
The Evidence for Replacing the Current Normalization of Youth Drug Use with a New Health Standard
Robert L. DuPont, MD, President, Institute for Behavior and Health; Clinical Professor of Psychiatry, Georgetown University School of Medicine, Rockville, MD
4:15 - 5:15 PM
Youth SUD Case-Based Panel
Ann B. Bruner, MD, Pediatrician, Mountain Manor Treatment Center, Baltimore, MD
Marc Fishman, MD, FASAM, Medical Director, Maryland Treatment Centers; Addiction Psychiatrist, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Rockville, MD
Robert L. DuPont, MD, President, Institute for Behavior and Health; Clinical Professor of Psychiatry, Georgetown University School of Medicine, Rockville, MD
Moderator: Leslie R. Dye, MD, FACMT, FASAM, FACCT, Clinical Professor, Emergency Medicine, Assistant Medical Director, Wright State University/Boonshoft School of Medicine, OneFifteen, Dayton, OH
Camille Broussard Robinson, MD, MPH
Assistant Professor of Pediatrics
Johns Hopkins University School of Medicine
Dr. Camille Broussard Robinson is an Assistant Professor of Pediatrics at the Johns Hopkins University School of Medicine in the Division of Adolescent & Young Adult Medicine. She is a public health-trained and board-certified Pediatrics, Adolescent Medicine, and Addiction Medicine specialist. She provides primary care and subspecialty consultative care to adolescents and young adults in the Center for Adolescent and Young Adult Health at Johns Hopkins Harriet Lane Clinic. Additionally, she provides subspecialty care for adolescents and young adults with Chronic Fatigue Syndrome, Postural Orthostatic Tachycardia Syndrome (POTS), and Long COVID in the Johns Hopkins Children’s Center Chronic Fatigue Clinic. As a clinician-scientist, her focus has been on the equitable care of underserved, medically and socially complex adolescent and young adult populations.
Dr. Broussard Robinson serves in several leadership roles including as associate director for the Adolescent Medicine fellowship program at Johns Hopkins and as Director of Research for the Chronic Fatigue Program at Johns Hopkins Children’s Center. She is also committed to the provision of trauma- and resiliency-informed, structurally competent care of adolescents and young adults and is involved in undergraduate, graduate, and continuing medical education in this area.
Dr. Broussard Robinson earned her medical degree from the University of California, San Francisco and an MPH from the University of California, Berkeley. She then completed a residency in Pediatrics, fellowship in Adolescent Medicine, and training in Addiction Medicine at the Johns Hopkins University School of Medicine.
Ann Bruner, MD
Pediatrician
Mountain Manor Treatment Center
Dr. Bruner is the Medical Director of Young Adult Services at Maryland Treatment Centers. She supervises aspects of residential treatment, detox services, and aftercare/outpatient services and has extensive experience in the diagnosis and management of opioid use disorders. She is graduate of Brown University and Columbia College of Physicians and Surgeons. Dr. Bruner completed her residency in General Pediatrics at Childrens National Medical Center in Washington DC, a fellowship in Community Health with the National Association of Community Health Centers, and a fellowship in Adolescent Medicine at Johns Hopkins Hospital. She is Board Certified in Adolescent Medicine and Addiction Medicine. Prior to working at Maryland Treatment Centers, Dr. Bruner worked at the Johns Hopkins University Student Health and Wellness Center. She is an Adjunct Professor of Pediatrics at the Johns Hopkins School of Medicine.
Jordan Davidson
Communications and Legislative Affairs Officer
Smart Approaches to Marijuana (SAM)
Jordan Davidson serves as SAM’s Communications and Legislative Affairs Officer. When he was 17 years old, Jordan entered long-term addiction recovery after struggling with cannabis use disorder. Prior to joining SAM, Jordan worked in Connecticut politics at the state and federal level. At SAM, Jordan is a principal legislative staffer managing federal policy on Capitol Hill. Jordan helped shepherd the passage of the Medical Marijuana and Cannabidiol Research Expansion Act, the first-ever marijuana reform bill signed into law. He has also led the successful efforts to defeat Congressional passage of the MORE, States Reform, Cannabis Administration and Opportunity, and SAFE Banking Acts. Since he joined SAM in 2019, Jordan has specialized in youth outreach and substance abuse prevention. He has been invited as a guest speaker by organizations and members of Congress across the country. Jordan has a degree in Political Science from American University in Washington, D.C.
Robert L. DuPont, MD
President; Clinical Professor of Psychiatry
Institute for Behavior and Health; Georgetown University School of Medicine
For 50 years, Robert L. DuPont, MD has been a leader in substance use disorder treatment and prevention. He was the first Director of the U.S. National Institute on Drug Abuse (1973-1978) and the second White House Drug Chief (1973-1977). From 1968-1970 he was Director of Community Services for the District of Columbia Department of Corrections. From 1970-1973, he served as Administrator of the District of Columbia Narcotics Treatment Administration. In 1978 he became the founding President of the Institute for Behavior and Health, Inc., a non-profit research and policy organization that identifies and promotes powerful new ideas to reduce drug use and addiction. A graduate of Emory University, Dr. DuPont received an MD degree in 1963 from the Harvard Medical School. He completed his psychiatric training at Harvard and the National Institutes of Health in Bethesda, Maryland. Dr. DuPont has been Clinical Professor of Psychiatry at the Georgetown University School of Medicine since 1980. His most recent book is Chemical Slavery: Understanding Addiction and Stopping the Drug Epidemic.
Leslie R. Dye, MD, FACMT, FASAM, FACCT
Interim Medical Director, OneFifteen
Clinical Professor, Wright State University/Boonshoft School of Medicine
Leslie R. Dye, MD is triple board certified in emergency medicine, medical toxicology, and addiction medicine. She has worked in the fields of medical toxicology and addiction medicine for 30 years. In addition to her clinical expertise, she has academic and business content expertise from experiences as an editor-in-chief (EIC) of a peer-reviewed medical journal (Journal of Medical Toxicology) and EIC of physician and pharmacist content production for a leading international medical digital content provider. Her deep subject matter expertise is demonstrated in her role as senior editor of the textbook, Case Studies in Medical Toxicology, author of 18 peer reviewed publications and 16 textbook chapters, 66 national and 11 international presentations, 10 various commentaries, interviews, and podcasts. Her leadership skills have been proven in both corporate and academic environments, as professor at a medical school, long-term board member and past president of the American College of Medical Toxicology, Chair of the Addiction Medicine Committee, former co-chair, and co-moderator of the AACT Acute and Intensive Care Symposium, and as the manager of as many as 30 team members at an international corporation. She received a funded grant that enabled her to start the first poison control center in mainland China and trained 6 Chinese physicians in the field of medical toxicology over 3 years in the US. Dr. Dye is experienced in and continues to provide medical care in remote polar regions with no access to advanced medical facilities.
Marc Fishman, MD, FASAM
Medical Director
Maryland Treatment Centers
Marc Fishman MD is an addiction psychiatrist and a member of the faculty of the Department of Psychiatry at the Johns Hopkins University School of Medicine. He leads Maryland Treatment Centers, a regional provider of addiction and co-occurring treatment for adolescents and adults. His academic work has focused on SUD treatment in youth, opioid addiction, SUD medications, and co-occurring disorders treatment. He was a co-editor of recent editions of the ASAM Criteria. He is a past President of the Maryland Society of Addiction Medicine and a current member of its Board.
Ashley Haynes, MD, FACEP
Medical Toxicologist, Addiction Medicine Specialist
Veterans Health Administration
Dr. Haynes completed training in a combined emergency medicine-internal medicine program in 2014, and a toxicology fellowship at UTSW in 2016. She has been treating substance use disorders as part of her practice since that time and is board certified in addition medicine. She currently works for the VA at the Robert J Dole Veterans Medical Center in Wichita, KS, treating patients in a residential treatment center, as well as clinic, and performing bedside consults.
Robert Cole Pueringer, MD
Medical Toxicologist and Addiction Medicine Specialist
Essentia Health
Dr. Robert “Cole” Pueringer is a Medical Toxicologist, Addiction Medicine Specialist, and Hospitalist. He joined Essentia Health in September of 2022. He completed his medical training in the Twin Cities, including Medical School at the University of Minnesota, Internal Medicine Residency and Chief Resident year at Hennepin County Medical Center (HCMC). He received his CTropMed certification for Tropical Medicine & Travelers’ Health at the University of Minnesota. He then completed a Medical Toxicology fellowship at the Health Partners Institute/HCMC in 2021 and an Addiction Medicine fellowship at the University of Minnesota in 2022. His academic interests include medical education, Global Health, and the overlap of Medical Toxicology and Addiction Medicine. He is particularly passionate about substance use disorder - a disease that has affected many aspects of his own life – and hopes to contribute significantly to substance use treatment, education, de-stigmatization, and harm reduction in northern Minnesota.
Kevin Wenzel, PhD
Psychologist and Director of Research
Maryland Treatment Centers, Mountain Manor Treatment Center
Kevin Wenzel, PhD is a clinical psychologist and the director of research at Maryland Treatment Centers. There, he oversees a portfolio of clinical research related to substance use disorder. Dr. Wenzel has served as a principal or co-investigator on a number of NIH-funded clinical trials related to the treatment of opioid use disorder with a special focus on initiation and retention on relapse prevention medications, especially among young adults. In addition to his primary research endeavors, he oversees a clinical training program for psychology students at MTC and provides regular trainings for clinical staff.
Registration Rates
Registration includes:
- Access to the in-person event on April 11, 2024
- Access to the on-demand recordings for 90 days after the event
- Access to the Speaker slides
- Downloadable Certificate of Attendance
| ACMT Member Rates | Early-Bird Expires: Feb 20, 2024 | Regular Rate Begins: Feb 21, 2024 |
|---|---|---|
Member Tier I: Full, Affiliate, International, Emeritus |
$250 | $300 |
Member Tier II: Fellows |
$200 | $250 |
Member Tier III: Residents, International - Developing Country |
$125 | $175 |
Member IV: Medical Students |
$100 | $150 |
| Non-Member Rates | Early-Bird Expires: Feb 20, 2024 | Regular Rate Begins: Feb 21, 2024 |
|---|---|---|
Non-member Tier I: Physicians, Pharmacists, Lawyers, "Other" |
$350 | $400 |
Non-member Tier II: Fellows, SPIs, Nurses, etc. |
$250 | $300 |
Non-member Tier III: Educators & Emergency Responders |
$175 | $225 |
Non-member IV: Residents & Students | $150 | $200 |
Early-Bird Rate
Early-bird rates expire at midnight on FEBRUARY 20, 2024. Fees increase to the Regular Rate after this date, no exceptions.
ACMT Membership
ACMT Members receive a discounted rate. Interested in becoming an ACMT Member? Contact our Membership Manager at membership@acmt.net. Learn more at: www.acmt.net/membership
Continuing Education
Continuing Education credit for this activity is available for an additional fee and is provided by AKH Inc., Advancing Knowledge in Healthcare. The activity is accredited for both live and enduring participation for the following:
- Physicians (Continuing Medical Education)
- Pharmacists (Continuing Pharmacy Education)
- Nurses (Continuing Nursing Education)
Cancellation Policy
Event registration cancellations received on or before February 25, 2024 (2/25/24) will receive a full refund less a 8% processing fee. Cancellations received between February 26, 2024 and March 26, 2024 (2/26/24-3/26/24) will receive a 50% refund. Cancellations made on or after March 27, 2024 (3/27/24) will not receive a refund. All Continuing Education registrations will be refunded in full less an 8% processing fee regardless of date.
All cancellation requests must be made in writing and emailed to: events@acmt.net. No telephone cancellations will be accepted. A refund that results from a cancellation or change to your registration will be returned to the original payer and in the original method of payment.
Pending review, limited exceptions will be made based on need and circumstance and must be submitted in writing to events@acmt.net. Because each exception must undergo a review and approval process, we ask in advance for your patience.
Questions?
Write to: events@acmt.net
Continuing Education
Continuing Education credit for this activity will be provided by AKH Inc., Advancing Knowledge in Healthcare.
In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and American College of Medical Toxicology (ACMT). AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. If you are seeking continuing education credit for a specialty not listed above, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.
CME, CPE, and CNE Continuing Education credits are pending for this activity. It is expected that learners will receive up to 5.50 Interprofessional Continuing Education (IPCE) credit for learning and change.
Key:
Complete
Next
Failed
Available
Locked